Prevalence of dementia in mainland China, Hong Kong, and Taiwan: an updated systematic review and meta-analysis
International Journal of Epidemiology
Oxford University Press (OUP) for International Epidemiological Association
Reason for embargo
Currently under an indefinite embargo pending publication by OUP. 12 month embargo required on publication
Background There are several existing systematic reviews of prevalence of dementia for mainland China, Hong Kong, and Taiwan but several studies have been newly reported. The aim of this study is to update prevalence data in this region and test for variation across geographical areas and time periods using the new dataset. Methods Twenty prevalence studies identified from World Alzheimer Report 2015 (January 2011– March 2015) and an updated search (March 2015–February 2017) were added to the original dataset (N=76). Meta-regression was used to investigate geographical variation and time trends taking methodological factors and characteristics of study population into account and estimate prevalence and number of people with dementia by geographical areas. Results Compared to northern China, the prevalence of dementia was lower in the central (-1.0; 95%CI:-2.2,0.3), south (-1.7; 95%CI:-3.1,-0.3), Hong Kong and Taiwan (-3.0; 95%CI: -5.0,-1.0) but appeared to be higher in western China (2.8; 95%CI: 0.1,5.5) after adjusting for 4 methodological variation. The increasing trend from pre-1990 to post-2010 periods was considerably attenuated when taking into account methodological factors and geographical areas. The updated estimated number of people with dementia in all these areas is 9.5 million (5.3%; 95%CI: 4.3,6.3) in the population aged 60 or above. Conclusions Geographical variation in dementia prevalence is confirmed in this update while evidence on increasing trends is still insufficient. Different societal development across areas provides an opportunity to investigate risk factors at the population level operating across diverse lifecourse experiences. Such research could advance global primary prevention on dementia.
The World Alzheimer Report 2015 is supported by Alzheimer Disease International (http://www.alz.co.uk/). AMP is supported by the UK Medical Research Council (MR/K021907/1).
This is the author accepted manuscript.
Awaiting citation and DOI